This page shows the publications co-authored by David Zurakowski and Deborah Dillon.
A quantitative method for screening and identifying molecular targets for nanomedicine. J Control Release. 2017 Oct 10; 263:57-67.
ICAM-1 as a molecular target for triple negative breast cancer. Proc Natl Acad Sci U S A. 2014 Oct 14; 111(41):14710-5.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.